test 4 Flashcards

1
Q

What is a significant predictor of mortality in cardiac surgery

A
  • RBC transfusion
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

AABB recommends

A
  • looking at symptoms rather than just the hgb number
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Transfusion risks: Infectious

A

◦ Bacterial
◦ Hepatitis
◦ HIV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Transfusion risks: Non Infectious - Febrile Reactions

A

 Fever, chills
 Pt antibodies are reacting with white cell antigens or white cell fragments in the transfused blood products.
 -OR- due to cytokines which accumulate during storage.
 Most common with platelet transfusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Transfusion risks: Non Infectious - Uticarial (Allergic) Reactions

A
  • rash
     1% of population
     Urticaria, puritis, flushing
     Caused by foreign proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Transfusion risks: Non Infectious - Anaphylactic Reactions

A

 Hypotension, tachycardia, cardiac arrhythmia, shock, cardiac arrest
 caused by patients who have IgA deficiency who have anti-IgA antibodies.
 Require special washed/ tested blood products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Transfusion risks: Non Infectious - Acute Hemolytic Reactions

A

 Caused by transfusion of ABO incompatible blood

 Chills, fever, pain, hypotension, dark urine, uncontrolled bleeding due to DIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Transfusion risks: Non Infectious - Volume Overload

A
  • not seen on bypass
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Transfusion risks: Non Infectious - Hypothermia

A
  • not seen on bypass

 Caused by transfusion of too many cold blood products

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Transfusion risks: Non Infectious - Citrate Toxicity

A

 Metabolized by liver
 Rapid transfusion of large quantity of blood products
 Binds calcium and magnesium – depleting stores
 Myocardial depression
 Coagulopathy
- combat by giving Ca2+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Transfusion risks: Non Infectious - Potassium Effects

A

 Stored RBC leak K+
 Irradiation increased the rate of leak
 Cardiac effects
- combat by washing the cells or Z-buff

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Transfusion Related Acute Lung Injury (TRALI)

A

◦ Symptoms: Similar to ARDS (Acute respiratory distress syndrome)
 Hypotension, Fever, Dyspnea, Tachycardia
◦ Non-Cardiogenic pulmonary edema with diffuse bilateral pulmonary infiltrates on CXR (chest xray)
◦ Occurs within 6 hours of tx
 Most cases present w/in 1-2 hours
◦ All blood products are culprits
◦ Occurs 1/2000 transfusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Transfusion Related Acute Lung Injury (TRALI) Pathophysiology

A

 Pathophysiology: Unclear.
◦ Attributed to HLA Antibodies, Granulocyte antibodies and biologically active mediators in the blood.
 Treatment: Ventilator support for ~96 hours
 Mortality: 5-10%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Transfusions associated with:

A

◦ Longer hospital stays
◦ Longer time to extubation
◦ Morbidity
◦ Mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Techniques to help minimize our impact on blood usage?

A
◦ Autologous transfusion
◦ Pre-bypass autologous donation
◦ Intraoperative Cell Saver use
◦ Shed mediastinal blood recovery
◦ Accept lower hematocrit
◦ Retrograde Autologous Priming
◦ Hemoconcentration
◦ Plasma/Platelet Pheresis
◦ Mini-circuits
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Blood conservation techniques (2)

A

 Bloodless Medicine

 Blood Conservation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is Bloodless Medicine

A

◦ MULTIMODALITY and MULTIDISCIPLINARY approach to patient care without the use of allogenic blood.
 AKA: Transfusion-Free Medicine
- USE EVERYTHING IN YOUR POWER TO NOT GIVE TRANSFUSION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is Blood Conservation

A

◦ Global concept aimed at REDUCING (doesn’t exclude the use) patient exposure
to allogenic blood products. Does not exclude use.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

History of giving blood

A

 Bloodless medicine used to be associated with Jehovah’s Witnesses
 Jehovah’s Witnesses refrain from accepting blood products due to religious beliefs
 Now Bloodless Medicine is used b/c studies have shown better patient outcomes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

History of giving blood with Jehovah’s Witnesses

A

 Jehovah’s Witnesses decision to refuse blood was religious, but they used scientific information regarding the side effects.
 A Booklet Blood, Medicine, and the law of God (1961) addressed the issues related to tx:
◦ Transfusion reactions
◦ Transfusion related syphilis, malaria, hepatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

1960’s

A

 1960’s – Not easy to refuse blood on religious grounds
◦ Frequently obtained court orders to give blood
 JW Representatives started meeting with doctors to explain why transfusions were refused
◦ Offered literature with techniques JWs accepted
◦ “Transfusion alternatives”
- it must be one continuous circuit and needs to be primed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Denton Cooley (Early 1960’s)

A

 Published article in the American Journal of Cardiology (1964) titled Open heart surgery in the Jehovah’s Witness”
 Described his techniques for treating these patients
 1977 – reported experience with 500 JW patients
 Adoption of bloodless surgery spread worldwide
 Not a particular technique, but the spirit and attitude toward the approach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Military and blood management

A

 Did surgery on wounded soldiers before transfusions were even available
 Confronted with blood loss, but no way to replace the blood
◦ Stopped the hemorrhage promptly and effectively
◦ Avoid further blood loss
 Surgical skill is a major factor in need of blood!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

World War I

A

◦ Blood Anticoagulation
 Allowed for transport of blood to the wounded
 PROBLEM: Storage!

25
World War II
◦ Storage problem overcome with the advent of blood banks
26
Military and blood management: 1953
 Use of blood alternatives ◦ Switched from plasma to Dextran (volume expander)  Sugar substrate  Due to incidence of hepatitis transmittal
27
Military and blood management: 1985
 Started looking into “blood substitutes” | ◦ Searched for oxygen carrier
28
Military and blood management: Introduction of Cell Savers
◦ Surgeon Gerald Klebanoff (Vietnam Vet) introduced the first cell saver in a military hospital.
29
Military and blood management: Recombinant Factor VIIa
◦ Hemopheliacs | ◦ Israeli army discovered potential to stop life threatening hemorrhage
30
What you need for a bloodless management program
 Hospital Commitment - EVERYONE (Administration, Physicians, Nurses, etc.)  Coordinator to recruit physicians dedicated to the mission in a variety of specialties
31
What can be done pre-op: Obtain a focused history
◦ Age – tolerance of anemia is age dependent  Elderly don’t tolerate  As age increases, risk of transfusion increases ◦ Gender – women are more likely than men to get transfused  Lower hct and prone to blood loss with menses ◦ Weight/Height – required to do calculations  Small patients and obese patients are at risk for transfusion  Race/ Ethnicity/ Background/ Religion  Anemia and Coagulation disorders are associated with certain races
32
What can be done pre-op: Ask about patient-related obstacles to transfusion-free therapy
``` ◦ Anemia ◦ Hemostatic disturbances ◦ Medical conditions increasing perioperative blood loss ◦ Obstacles to surgical hemostasis ◦ Factors decreasing anemia tolerance ```
33
What can be done pre-op: Lab work
◦ Hgb ◦ PT/INR / PTT ◦ Platelet Count and Platelet Function Tests
34
What can be done pre-op: Treat any anemia
◦ Optimize Hgb prior to surgery
35
What can be done pre-op: Treat Polycythemia (increased number of red blood cells in the blood)
◦ Risk of hemorrhage during surgery (hyperviscosity) | ◦ Plebotomy
36
What can be done pre-op: Avoid pharmacological coagulopathies
◦ Drugs (not anticoagulants) that have increased bleeding risk
37
What can be done pre-op?
```  Obtain a focused history  Ask about patient-related obstacles to transfusion-free therapy  Lab work  Treat any coagulopathies  Treat any anemia  Treat Polycythemia  Avoid pharmacological coagulopathies ```
38
Anesthesia resource to help blood management
 Help correct any coagulopathies/anemia preop.  Help position the patient to decrease blood loss  Provide controlled hypotension  Keeping patient warm ◦ Optimizes clotting  Choice of Drugs  Timing of fluid administration ◦ Restrict until surgical hemostasis is achieved  Intravascular pressure is not too high
39
Autologous Donation
◦ Donation where the donor and recipient are identical  Patient donates blood to be used on themselves during surgery.  Avoids use/ risks of donor blood  May not be practical or cost effective for most cardiac surgeries  Requires a hematocrit of 33%  Donation of whole blood can be split ◦ Allows not only donation of RBC, but also FFP ◦ Requires special order from physician  Plateletpheresis and Plasmapheresis ◦ Allows the donation of platelets and plasma
40
Autologous Donation Contraindications
``` ◦ Recent MI ◦ CHF ◦ Aortic Stenosis ◦ Transient Ischemic Attacks ◦ Hypertension ◦ Unstable Angina ◦ Bacteremia ```
41
Prebypass autologous normovolemic hemodilution
- donate to yourself but do not change your volume by adding crystalloid  Spares platelets from bypass ◦ Retain/ preserve function  Requires a hct of 35%  Remove about 500-1000mL (1-3 units) ◦ Depends on starting hct ◦ Depends on age of patient ◦ Depends on BSA ◦ Depends on coexisting conditions  Blood is placed in a bag with anticoagulant ◦ Usually CPD (citrate-phosphate-dextrose)  Reinfused after protamine is administered
42
Prebypass autologous normovolemic hemodilution Contraindications
``` ◦ COPD ◦ CHF ◦ CAD (CABG) ◦ Unstable Angina ◦ Renal Insufficiency ◦ Severe Aortic Stenosis ◦ Coagulopathy ```
43
Retrograde autologous priming (RAP)
 Performed prior to bypass  Arterial and venous cannula are in place  Use the patient’s blood pressure to displace prime.  Remove prime via: ◦ Stopcock on ALF ◦ Arterial sampling manifold ◦ Y’s in circuit  Can be done quickly  Must closely watch patient’s pressures ◦ Remove about 200-600mL of Prime
44
Dry venous Line
 Requires the use of VAVD  Venous line is emptied prior to connection to the venous cannula  Volume is removed to a bag and discarded or sequestered  Eliminates about 400-1000mL  Cautions: ◦ Only works if patient has adequate volume pre-op ◦ If patient is dry (not a lot of volume), will need the volume anyways
45
Mini-circuits
```  AKA: Miniaturized Extracorporeal Circuits  Decreases foreign surface area  Decreases prime volume  Decreases blood-air contact  Attempt to: ◦ Decrease hemodilution ◦ Decrees inflammatory response ◦ Decrease volume shifts ```
46
What are mini-circuits
 Closed A-V Loop with centrifugal pump, membrane oxygenator, coated tubing ◦ No venous reservoir ◦ No cardiotomy ◦ Often no heat exchanger or arterial line filter ◦ Centrifugal pump provides kinetic assisted venous drainage and blood flow  Prime volume is about 500mL ◦ Can be decreased with RAPing  Used mostly for CABGs ◦ Some valves have been done
47
Types of Mini-circuits (2)
◦ Totally Integrated Devices  Include air handling and elimination systems, centrifugal pump and membrane oxygenator. ◦ Combination of components
48
Benefits of Mini-circuits
◦ Less inflammatory reaction ◦ Less activation of coagulation and fibrinolysis ◦ Less hemodilution ◦ Less use of autologous blood ◦ Marginally improved renal and neurological function  Results in the studies are mixed
49
Concerns of Mini-circuits
◦ Air handling ◦ Requires surgeon to take care to avoid air entrapment around the cannula ◦ More microemboli with MECCs compared to normal circuits ◦ No reservoir = no way to handle excess volume ◦ No immediate volume infusion ◦ No heat exchanger (on most) ◦ Use of separate cell saver (Delay in processing, loss of factors/platelets) ◦ Increased cost ◦ Adaptability when surgical complications/ need requires normal ECC
50
Ways of making our regular circuits mini without using a mini-circuit
```  Cut lines short  Get as close to the table as possible  Elevate the reservoir ◦ Use VAVD  Put modular pump heads near outlet/inlet of oxygenator  Dry venous line ◦ Requires VAVD  Go on with low prime volume ```
51
Ultrafiltration / Hemoconcentration
 Filtration of water across a semipermeable membrane via hydrostatic pressure gradient  Water crosses the membrane which creates a solute concentration gradient  Solutes have a higher concentration in blood so they move to the water side which has a lower solute concentration  So, we’re removing “water”  And electrolytes
52
Modified Ultrafiltration (MUF)
 Withdrawing blood from the patient via the arterial line (post bypass)  Running the blood through a hemoconcentrator  Pumping the blood back into the patient via the venous line.  Can use the cardioplegia circuit ◦ Make sure to flush out the cardioplegia solution with blood ◦ Pump flow rate less than MUF flow rate
53
Cell Salvage intraoperative
 Use heparinized saline or CPD as an anticoagulant  Cells are separated from the fluid by a centrifuge ◦ RBC fall to the bottom, Plasma on top  RBC washed with 3x bowl volume (min)  Put in a reinfusion bag for administration  Removes: Fat, air, tissue debris, potassium, hormones, bioactivators, etc.
54
Limitations of cell salvage
``` ◦ Delay in processing ◦ Loss of plasma proteins ◦ Loss of coagulation factors and platelets ◦ Expense ◦ Operator attention and time ```
55
Reinfusion of shed blood
 Blood collected from the mediastinum and pleural cavities post op can be reinfused ◦ Doesn’t clot due to defibrination ◦ Increased level of free Hgb ◦ Contains activated products  ***NOT ideal ◦ Used in urgent situations ◦ Can be processed
56
Cardiopat
 Shed blood can be collected and processed by a cell processing device – Cardiopat  Uses a dynamic disk to process. ◦ Processes a variable volume of blood  Consistently delivers washed RBCs w/ hct of 70-80%  Processes up to 2 liters per hour or as little as 5 mL of RBCs
57
ACCEPTANCE OF LOWER HEMATOCRIT
 Acceptable level varies by institution  Healthy, Good LV Function ◦ Tolerate 20-25%  Those with limited coronary flow, increased metabolic needs, respiratory issues will require increased hematocrits
58
Overall conclusion for blood conservations
 Blood conservation is a team approach  Everyone involved in each step of a patient’s care need to be on board ◦ Primary care physicians, nurses, surgeons, anesthesiologists, perfusionists, residents/ fellows ◦ One player not on board can significantly alter the course of that patient’s care.